Autologous Osteoblast Transplantation, an Innovative Method of Bone Defect Treatment: Role of a Tissue and Cell Bank in the Process

作者:Olender E*; Brubaker S; Uhrynowska Tyszkiewicz I; Wojtowicz A; Kaminski A
来源:Transplantation Proceedings, 2014, 46(8): 2867-2872.
DOI:10.1016/j.transproceed.2014.09.071

摘要

Background. The idea of cell treatment of various diseases and medical conditions has become very popular. Some procedures are well established, as is autologous chondrocyte implantation, whereas others are still in the process of early development, laboratory experiments, and some clinical trials. %26lt;br%26gt;Methods. This report is devoted to an example of an emerging cell treatment: bone augmentation with the use of autologous cells and its legal and technical background. Various requirements set by law must be met by tissue banks performing cell seeding of grafts. In Europe, the requirements are described in directives 2004/23/EC, 2006/17/EC, 2006/86/EC, and in the regulation 2007/1394/EC. %26lt;br%26gt;Results. Revitalization of biostatic allografts gives new, promising tools for creation of functional parts of organs; brings the methodology used in tissue banks closer to tissue engineering; places the enterprise in the mainstream of advanced biotechnology; allows the full potential of tissue allografts; and opens a new, large area for clinical and laboratory research. Cell and tissue processing also have a financial impact on the treatment: it produces additional expenditures. %26lt;br%26gt;Conclusions. Clinical effectiveness will be the most decisive factor of whether this innovative treatment will be applied in a particular type of medical condition. From a tissue establishment perspective, the most important issue is to develop a procedure that ensures safety for the patient in graft quality terms.

  • 出版日期2014-10